Anti-TNF-α therapies: the next generation

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Nature reviews. Drug discovery

• Publication date

  2003-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nrd1175
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Embryotoxic effects of thalidomide derivatives in the non-human primate Callithrix jacchus

  2004cited by this paper
• Embryotoxic effects of thalidomide-derivatives in the non-human primate Callithrix jacchus

  2004cited by this paper
• Sensitizing Anthrax Lethal Toxin-resistant Macrophages to Lethal Toxin-induced Killing by Tumor Necrosis Factor-α*

  2003cited by this paper
• Anti-TNFalpha therapy for rheumatoid arthritis: an update.

  2003cited by this paper
• Theophylline and PDE4 inhibitors in asthma

  2003cited by this paper
• Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives.

  2003cited by this paper
• First proteasome inhibitor approved for multiple myeloma.

  2003cited by this paper
• Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma.

  2003cited by this paper
• BMS-345541 Is a Highly Selective Inhibitor of IκB Kinase That Binds at an Allosteric Site of the Enzyme and Blocks NF-κB-dependent Transcription in Mice*

  2003cited by this paper
• Thalidomide analogs as emerging anti-cancer drugs

  2003cited by this paper
• Calagualine inhibits nuclear transcription factors-kappaB activated by various inflammatory and tumor promoting agents.

  2003cited by this paper
• Inhibition of the NF-κB signaling pathway mediates the anti-inflammatory effects of petrosaspongiolide M

  2003cited by this paper
• A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins.

  2003cited by this paper
• RANK‐Fc in myeloma

  2002cited by this paper
• The inflammatory reflex

  2002cited by this paper
• The story so far

  2002cited by this paper
• Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects

  2002cited by this paper
• Signaling Molecules of the NF-κB Pathway Shuttle Constitutively between Cytoplasm and Nucleus*

  2002cited by this paper
• Kaurane Diterpene, Kamebakaurin, Inhibits NF-κB by Directly Targeting the DNA-binding Activity of p50 and Blocks the Expression of Antiapoptotic NF-κB Target Genes*

  2002cited by this paper
• The alveolar macrophage: the Trojan horse of Bacillus anthracis.

  2002cited by this paper
• Differential effects between marimastat, a TNF-α converting enzyme inhibitor, and anti-TNF-α antibody on murine models for sepsis and arthritis

  2002cited by this paper
• Development status of second generation PDE4 inhibitors for asthma and COPD: the story so far.

  2002cited by this paper
• Recent advances in PDE4 inhibitors as immunoregulators and anti-inflammatory drugs.

  2002cited by this paper
• Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents.

  2002cited by this paper
• Macrophage Apoptosis by Anthrax Lethal Factor Through p38 MAP Kinase Inhibition

  2002cited by this paper
• Protective Antitumor Immunity Induced by a Costimulatory Thalidomide Analog in Conjunction with Whole Tumor Cell Vaccination Is Mediated by Increased Th1-Type Immunity1

  2002cited by this paper
• Immunological effects of thalidomide and its chemical and functional analogs.

  2002cited by this paper
• Suppression by a sesquiterpene lactone from Carpesium divaricatum of inducible nitric oxide synthase by inhibiting nuclear factor-kappaB activation.

  2001cited by this paper
• Thalidomide for previously untreated indolent or smoldering multiple myeloma

  2001cited by this paper
• Current status of thalidomide in the treatment of cancer.

  2001cited by this paper
• Uncoupling of inflammatory and destructive mechanisms in arthritis

  2001cited by this paper
• [The ubiquitin-proteasome system: the relationship between protein degradation and human diseases].

  2001cited by this paper
• VX-745. Vertex Pharmaceuticals.

  2001cited by this paper
• The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase.

  2001cited by this paper
• Identification of the cellular receptor for anthrax toxin

  2001cited by this paper
• Resistance of bone marrow-derived macrophages to apoptosis is associated with the expression of X-linked inhibitor of apoptosis protein in primary cultures of bone marrow cells.

  2001cited by this paper
• Kaurane diterpenes from Isodon japonicus inhibit nitric oxide and prostaglandin E2 production and NF-kappaB activation in LPS-stimulated macrophage RAW264.7 cells.

  2001cited by this paper
• Kif1C, a kinesin-like motor protein, mediates mouse macrophage resistance to anthrax lethal factor.

  2001cited by this paper
• Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.

  2000cited by this paper
• Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-alpha and not by Fas ligand.

  2000cited by this paper
• Thalidomide in multiple myeloma.

  2000cited by this paper
• A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma.

  2000cited by this paper
• Thalidomide in the treatment of relapsed multiple myeloma.

  2000cited by this paper
• Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNγ‐induced release of NO and TNFα

  1999cited by this paper
• Proteasome Activity Is Required for Anthrax Lethal Toxin To Kill Macrophages

  1999cited by this paper
• Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD).

  1999cited by this paper
• IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.

  1999cited by this paper
• Lethal toxin actions and their consequences

  1999cited by this paper
• Anthrax lethal factor cleaves the N‐terminus of MAPKKS and induces tyrosine/threonine phosphorylation of MAPKS in cultured macrophages

  1999cited by this paper
• Immune response to a recombinant human TNFR55-IgG1 fusion protein: auto-antibodies in rheumatoid arthritis (RA) and multiple sclerosis (MS) patients have neither neutralizing nor agonist activities.

  1999cited by this paper
• A Critical Role of the p75 Tumor Necrosis Factor Receptor (p75TNF-R) in Organ Inflammation Independent of  TNF, Lymphotoxin α, or the p55TNF-R

  1998cited by this paper
• The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor.

  1998cited by this paper
• Tumor necrosis factor (TNF) receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1

  1998cited by this paper
• Role of IKK1 and IKK2 in Lipopolysaccharide Signaling in Human Monocytic Cells*

  1998cited by this paper
• Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.

  1998cited by this paper
• Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study

  1998cited by this paper
• Anthralin stimulates keratinocyte-derived proinflammatory cytokines via generation of reactive oxygen species

  1998cited by this paper
• Supraoptimal Peptide–Major Histocompatibility Complex Causes a Decrease in Bcl-2 Levels and Allows Tumor Necrosis Factor α Receptor II–mediated Apoptosis of Cytotoxic T Lymphocytes

  1998cited by this paper
• Ltx1, a mouse locus that influences the susceptibility of macrophages to cytolysis caused by intoxication with Bacillus anthracis lethal factor, maps to chromosome 11

  1998cited by this paper
• An essential role for ectodomain shedding in mammalian development.

  1998cited by this paper
• DBA/1 mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition.

  1997cited by this paper
• Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α

  1997cited by this paper
• Crystal structure of the anthrax toxin protective antigen

  1997cited by this paper
• A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling

  1997cited by this paper
• Cytokine production in synovial tissue of mice with collagen‐induced arthritis (CIA)

  1997cited by this paper
• Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat.

  1997cited by this paper
• In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis

  1997cited by this paper
• Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents.

  1996cited by this paper
• Role of IB Ubiquitination in Signal-induced Activation of NF-B in Vivo(*)

  1996cited by this paper
• Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-alpha response from alveolar macrophages.

  1995cited by this paper
• Induction of apoptosis in mature T cells by tumour necrosis factor

  1995cited by this paper
• Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of the teratogenic action of thalidomide.

  1995cited by this paper
• Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis.

  1995cited by this paper
• The type I interleukin‐1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF‐transgenic mice

  1995cited by this paper
• Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram- negative sepsis

  1994cited by this paper
• Coley's toxins, tumor necrosis factor and cancer research: a historical perspective.

  1994cited by this paper
• Embryotoxic effects of thalidomide derivatives in the non-human primate Callithrix jacchus. 5. Lack of teratogenic effects of phthalimidophthalmide.

  1994cited by this paper
• On the role of macrophages in anthrax.

  1993cited by this paper
• Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14.

  1993cited by this paper
• Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor.

  1993cited by this paper
• Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.

  1992cited by this paper
• Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

  1990cited by this paper
• A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.

  1989cited by this paper
• Isolation and characterization of a tumor necrosis factor binding protein from urine

  1989cited by this paper
• Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.

  1988cited by this paper
• Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice.

  1988cited by this paper
• Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis.

  1988cited by this paper
• Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.

  1988cited by this paper
• Tumour necrosis factor in synovial exudates.

  1988cited by this paper
• A human inhibitor of tumor necrosis factor alpha

  1988cited by this paper
• A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF.

  1988cited by this paper
• Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process.

  1986cited by this paper
• Species differences in pharmacokinetics and drug teratogenesis.

  1986cited by this paper
• Multiple nuclear factors interact with the immunoglobulin enhancer sequences.

  1986cited by this paper
• Differences in susceptibility of inbred mice to Bacillus anthracis

  1986cited by this paper
• Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

  1985cited by this paper
• Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor.

  1985cited by this paper
• Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells

  1985cited by this paper
• Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

  1984cited by this paper
• Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.

  1982cited by this paper

• Structural and molecular characterization of a small-molecule TNF-α-TNFR1 inhibitor modulating cell death signaling.

  2026cites this paper
• Association between exposure to brominated flame retardants and arthritis in US adults: Insights from epidemiological, mediation analysis, and network toxicology

  2026cites this paper
• Perinatal exposure to 4-hydroxy-4'-isopropoxydiphenylsulfone alters the adipogenesis in adult mice: A sex-specific study.

  2025cites this paper
• A Click Chemistry Approach for the Synthesis of Triazole Linked Vanillin Scaffolds as Potent Pharmacophores: Anti-Diabetic, Anti-Inflammatory, Antioxidant, Molecular Docking and ADMET Investigations

  2025cites this paper
• Core-Shell Codelivery Nanocarrier Synergistically Regulates Cartilaginous Immune Microenvironment for Total Meniscus Replacement.

  2025cites this paper
• Integrating in silico and in vitro approaches for identifying potential TNF-α inhibitors.

  2025cites this paper
• Precision engineering of adalimumab fab variants enhances TNF-α neutralization and structural stability.

  2025cites this paper
• RONS clearing TePt @ sodium carboxymethyl cellulose nanozymes for chronic enteritis therapy.

  2025cites this paper
• Supersulfide donors and their therapeutic targets in inflammatory diseases

  2025cites this paper
• Molecular determinants of TNFR1:TNFα binding and dynamics in a physiological membrane environment

  2025cites this paper
• Arginase-1 responsive lipid nanoparticles for cytosolic TNF-α-siRNA release to alleviate colitis

  2025cites this paper
• Inflammatory Pathways to Carcinogenesis: Deciphering the Rheumatoid Arthritis–Lung Cancer Connection

  2025cites this paper
• LZTR1 regulates epithelial MHC-I expression via NF-κB1 to modulate CD8+ T cells activation

  2025cites this paper
• Design of minibinder proteins as universal antagonists against canine and human TNFα

  2025cites this paper
• Modulation of LPS-induced RAW 264.7 macrophages by Pulsatilla koreana-synthesized gold nanoparticles

  2025cites this paper
• Hepatopancreatic and intestinal inflammation is induced by lipopolysaccharide from Microcystis in common carp via the TLRs/NF-κB pathway.

  2025cites this paper
• TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers

  2024cites this paper
• Implications of the non‐neuronal cholinergic system for therapeutic interventions of inflammatory skin diseases

  2024cites this paper
• Novel Diagnostic Biomarker BST2 Identified by Integrated Transcriptomics Promotes the Development of Endometriosis via the TNF-α/NF-κB Signaling Pathway

  2024cites this paper
• Tumor Necrosis Factor-Alpha: Ally and Enemy in Protean Cutaneous Sceneries

  2024cites this paper
• Gut microbiota derived short‐chain fatty acids in physiology and pathology: An update

  2024cites this paper
• Iridium(III) complexes as novel theranostic small molecules for medical diagnostics, precise imaging at a single cell level and targeted anticancer therapy.

  2024cites this paper
• Shared genomic segments analysis identifies MHC class I and class III molecules as genetic risk factors for juvenile idiopathic arthritis

  2024cites this paper
• Deep learning of multimodal networks with topological regularization for drug repositioning

  2024cites this paper
• Ultrasound-Guided Drug Delivery System Utilizing Piezocatalytic MoS2 Nanomaterials for Anti-Inflammatory Therapy

  2024cites this paper
• Biparatopic Nanobody-Based Immunosorbent for the Highly Selective Elimination of Tumor Necrosis Factor-α.

  2024cites this paper
• In silico molecular docking and ADMET study of Isodon coetsa phytochemicals targeting TNF‐α in inflammation‐mediated diseases

  2024cites this paper
• The Potential of Plant Polysaccharides and Chemotherapeutic Drug Combinations in the Suppression of Breast Cancer

  2024cites this paper
• Integration of blood separation and multiple-cytokine detection using a combined paper centrifugation–SERS immunoassay method

  2023cites this paper
• A Poly-D-Mannose Synthesized by a One-Pot Method Exhibits Anti-Biofilm, Antioxidant, and Anti-Inflammatory Properties In Vitro

  2023cites this paper
• Coupling methane and bioactive polysaccharide recovery from wasted activated sludge: A sustainable strategy for sludge treatment.

  2023cites this paper
• Skin and Soft Tissue Infections: Current Advancement in Epidemiology, Pathogenesis and Management

  2023cites this paper
• Recent progress and treatment strategy of pectin polysaccharide based tissue engineering scaffolds in cancer therapy, wound healing and cartilage regeneration.

  2023cites this paper
• Photoaffinity labeling coupled with proteomics identify PDI-ADAM17 module is targeted by (-)-vinigrol to induce TNFR1 shedding and ameliorate rheumatoid arthritis in mice.

  2023cites this paper
• Correlation of the Pro-Inflammatory Cytokines IL-1β, IL-6, and TNF-α, Inflammatory Markers, and Tumor Markers with the Diagnosis and Prognosis of Colorectal Cancer

  2023cites this paper
• The Role of Inflammation in the Pathogenesis of Psoriasis

  2023cites this paper
• Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFβ Signaling Pathways and COP1 in Metastasis

  2023cites this paper
• Functionally Masked Antibody to Uncouple Immune-Related Toxicities in Checkpoint Blockade Cancer Therapy.

  2023cites this paper
• Structure-Based Drug Design and Synthesis of Pyrrolidine-2,5-diones as Novel TNF-α Inhibitors

  2023cites this paper
• Ankylosing spondylitis: what all should anaesthesiologist know?

  2022cites this paper
• Identification of a binding site on soluble RANKL that can be targeted to inhibit soluble RANK-RANKL interactions and treat osteoporosis

  2022cites this paper
• SnoopLigase Enables Highly Efficient Generation of C-C-Linked Bispecific Nanobodies Targeting TNF-α and IL-17A.

  2022cites this paper
• BENEFÍCIOS DA TÉCNICA DE ULTRAFILTRAÇÃO COM BALANÇO ZERO (Z-BUF) DURANTE A CIRCULAÇÃO EXTRACORPÓREA EM PACIENTES SUBMETIDOS À CIRURGIA CARDÍACA

  2022cites this paper
• TNF-α Inhibitors and Other Biologic Agents for the Treatment of Immune Checkpoint Inhibitor-Induced Myocarditis

  2022cites this paper
• Optimizing study design in LPS challenge studies for quantifying drug induced inhibition of TNFα response: Did we miss the prime time?

  2022cites this paper
• Pharmacological effect of Lidang Tang against adjuvant-induced rheumatoid arthritis in rats

  2022cites this paper
• An update on emerging immunological targets and their inhibitors in the treatment of psoriasis.

  2022cites this paper
• Analgesic and Anti-Arthritic Activities of Polysaccharides in Chaenomeles speciosa

  2022cites this paper
• Oral administration of bovine lactoferrin suppresses the progression of rheumatoid arthritis in an SKG mouse model

  2022cites this paper
• Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases

  2022cites this paper
• A novel electrochemical biosensor based on the electrospun nanofibrous nanocomposites of PCL-PPy-MWCNT towards determination of TNF-α biomarker

  2022cites this paper
• Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19

  2022cites this paper
• Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome

  2022cites this paper
• Pathogenesis and management of fatigue in primary biliary cholangitis

  2022cites this paper
• Gaps and opportunities in sepsis translational research

  2022cites this paper
• Novel peptide inhibitor of human tumor necrosis factor-α has antiarthritic activity

  2022cites this paper
• Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes

  2022cites this paper
• Immunosuppressants

  2022cites this paper
• Janus kinase versus TNF inhibitors: where we stand today in rheumatoid arthritis

  2022cites this paper
• Anti-Inflammatory Effects of Compounds from Echinoderms

  2022cites this paper
• Anti-Inflammatory Nanotherapeutics by Targeting Matrix Metalloproteinases for Immunotherapy of Spinal Cord Injury.

  2021cites this paper
• Antioxidant, Anti-Inflammatory and Wound Healing of Biosynthetic Gold Nanoparticles Using Mangosteen (G. Mangostona)

  2021cites this paper
• Atomic Scale Interactions between RNA and DNA Aptamers with the TNF-α Protein

  2021cites this paper
• GC-MS Analysis and In Vitro Thrombolytic, Anti-hemolytic, Anti- Inflammatory Activities of Essential Oil of Citrus limetta Peel

  2021cites this paper
• Alignment of practices for data harmonization across multi-center cell therapy trials: a report from the Consortium for Pediatric Cellular Immunotherapy.

  2021cites this paper
• Seaweed as a Source of Natural Antioxidants: Therapeutic Activity and Food Applications

  2021cites this paper
• Sporotrichosis: Review of Innate and Acquired Immune Mechanisms

  2021cites this paper
• Abnormal saccharides affecting cancer multi-drug resistance (MDR) and the reversal strategies.

  2021cites this paper
• Targeting the gasdermin D as a strategy for ischemic stroke therapy.

  2021cites this paper
• Various Forms of Tuberculosis in Patients with Inflammatory Bowel Diseases Treated with Biological Agents

  2021cites this paper
• From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis

  2021cites this paper
• Spectrum and Management of Immune Related Adverse Events Due to Immune Checkpoint Inhibitors

  2021cites this paper
• Developing nociceptor-selective treatments for acute and chronic pain

  2021cites this paper
• Modeling and interaction analysis of the tumor necrosis factor-alpha with oligopeptides

  2021cites this paper
• Tuberculosis miliar paucibacilar secundaria al manejo con etanercept en artritis reumatoide. Reporte de caso

  2021cites this paper
• Down-regulation of TNF-α via macrophage-targeted RNAi system for the treatment of acute inflammatory sepsis.

  2021cites this paper
• Adalimumab and myositis: A case report and review of the French and international Pharmacovigilance Databases.

  2020cites this paper
• Therapeutic Cytokine Inhibition Modulates Activation and Homing Receptors of Peripheral Memory B Cell Subsets in Rheumatoid Arthritis Patients

  2020cites this paper
• Functional immune mapping with deep-learning enabled phenomics applied to immunomodulatory and COVID-19 drug discovery

  2020cites this paper
• Structural insight into TNF-α inhibitors through combining pharmacophore-based virtual screening and molecular dynamic simulation

  2020cites this paper
• ROLES OF TUMOR NECROSIS FACTOR IN ANIMAL TISSUES

  2020cites this paper
• TNF, IL-6, and IL-10 cytokines levels and their polymorphisms in renal function and time after transplantation

  2020cites this paper
• IN-VIVO PHARMACOLOGICAL ACTIVITIES OF METHANOL EXTRACT OF RHODODENDRON ARBORETUM (LEAVES) ON EXPERIMENTAL MICE

  2020cites this paper
• Discovery of an Orally Active Small Molecule TNF-α Inhibitor.

  2020cites this paper
• Potential molecular mechanisms of negative pressure in promoting wound healing

  2020cites this paper
• Therapeutic potential of sulfur-containing natural products in inflammatory diseases.

  2020cites this paper
• Inhibition of Skin Inflammation by Scytonemin, an Ultraviolet Sunscreen Pigment

  2020cites this paper
• Tumor Necrosis Factor-α Trimer Disassembly and Inactivation via Peptide-Small Molecule Synergy.

  2020cites this paper
• Recent advances of iridium(III) metallophosphors for health-related applications

  2020cites this paper
• Advanced Approaches in Immunotherapy for the Treatment of Type 1 Diabetes Mellitus

  2020cites this paper
• Ultrasmall Rhodium Nanozyme with RONS Scavenging and Photothermal Activities for Anti-Inflammation and Antitumor Theranostics of Colon Diseases.

  2020cites this paper
• Microwave-induced synthesis as a part of green chemistry approach for novel antiinflammatory agents

  2020cites this paper
• TNFα signalling predicts poor prognosis of patients with endometrial cancer.

  2020cites this paper
• Design and synthesis of 1,3-benzothiazinone derivatives as potential anti-inflammatory agents.

  2020cites this paper
• Roles Of Tumor Necrosis Factor In Animal Tissues : Review Article

  2020cites this paper
• The Emerging Roles of NDR1/2 in Infection and Inflammation

  2020cites this paper
• The role of immunosuppressive agents in the management of severe and refractory immune‐related adverse events

  2020cites this paper
• Functionalized Carbon Nanotube-Embedded Poly(vinyl alcohol) Microspheres for Efficient Removal of Tumor Necrosis Factor-α.

  2020cites this paper
• Inflammation in Atherosclerosis: From Theory to Practice

  2020cites this paper
• Current Developments in the Immunology of Psoriasis

  2020cites this paper